Title: Roberto Sommavilla - Innovator in Antibody Technology
Introduction
Roberto Sommavilla is an accomplished inventor based in Opfikon, Switzerland. He is currently employed at Esbatech, a Novartis Company LLC. With a focus on innovative solutions in the field of biotechnology, Sommavilla has made significant contributions to the development of antibody technologies.
Latest Patent Applications
Roberto Sommavilla's latest patent applications include the invention titled "Stable Multiple Antigen-Binding Antibody." This invention provides antibodies that bind to multiple antigens. These antibodies feature at least two antibody light chain variable domains and two antibody heavy chain variable domains. Each light chain variable domain is linked to a heavy chain variable domain to form a VH/VL construct. Notably, at least one of the VH domains comprises a specific amino acid at AHo position 12, 103, and/or 144, while at least one of the VL domains comprises a specific amino acid at AHo position 47 and/or 50. The invention also discloses nucleic acid molecules, vectors, and host cells for the expression of the recombinant antibodies, methods for isolating them, and their use in medicine.
Conclusion
Roberto Sommavilla is a notable inventor in the field of antibody technology, contributing to advancements that hold promise for medical applications. His work continues to influence the biotechnology landscape.